Cargando…
Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
Autores principales: | Choi, Jonggi, Lim, Young-Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233805/ https://www.ncbi.nlm.nih.gov/pubmed/27979732 http://dx.doi.org/10.1016/j.ebiom.2016.12.005 |
Ejemplares similares
-
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005) -
Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021) -
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
por: Butt, Amna Subhan, et al.
Publicado: (2012) -
Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)